Lumos Labs
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Lumos Labs sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).
Lumos Labs: 9 sponsored US clinical trials, none currently recruiting.
Lumos Labs sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. The most-studied condition in this pipeline is ADHD, with 2 trials.
Top-decile sponsor footprint
Lumos Labs ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
9 total, page 1 of 1
Brain Response to an Intervention Using Guided, At-Home Technology for the Mind
NCT05912556
An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms
NCT05805176
Task Atlas: Study to Develop a Task Atlas of Brain Recruitment During a Digital Game-based Program
NCT06376175
Guided ADHD Therapy for Managing the Extent and Severity of Symptoms
NCT05296473
An Observational Study of Lumosity in Seniors
NCT02614755
Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults
NCT02518204
An Online Study of the Reliability of the Brain Performance Test (BPT)
NCT02403609
Reliability and Validity of Online Cognitive Assessments
NCT02382393
Enhancing Cognitive Abilities With Comprehensive Training
NCT02367898
Therapeutic Areas
How the Lumos Labs archive is shaped
9 indexed studies, none listed as recruiting (0% open); 7 completed (78%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: ADHD (2 trials), 4 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Lumos Labs: archived-pipeline peers nationwide
Peers matched on 9 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Lumos Labs sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 9 archived trials
- 4D Molecular Therapeutics · 9 trials · 44% recruiting
- 9 Meters Biopharma · 9 trials · 0% recruiting
- Aadi Bioscience · 9 trials · 33% recruiting
- Ablynx, a Sanofi company · 9 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Lumos Labs page
9 registered trials is a research-attention snapshot, not an endorsement of Lumos Labs or any single study.
- None of Lumos Labs's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- ADHD is the condition Lumos Labs studies most, compare against other sponsors active in the same condition before evaluating a specific study. See ADHD trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Lumos Labs pipeline card: 9 registered trials from official public datasets.Report a data error.